Lv11
43 积分 2021-07-05 加入
Programmed cell death 1 inhibitor combined with chemotherapy compared to chemotherapy alone as first-line treatment in advanced gastric cancer patients: A real-world study
8天前
已完结
First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305
20天前
已完结
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
20天前
已完结
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study
25天前
已完结
Effectiveness of digital cognitive behavioral therapy for insomnia in nurses with shift work sleep disorder: Results of a randomized controlled trial
27天前
已完结
BLOOD GROUP FREQUENCIES IN ADMIRALTY ISLANDERS: FURTHER OBSERVATIONS ON THE FIJIANS AND INDONESIANS AND ON Rh GENE FREQUENCIES IN SOME OTHER RACES
1个月前
已完结
Efficacy of the First-line Immune Checkpoint Inhibitor plus Chemotherapy for Gastroesophageal Cancer: A Meta-analysis of Phase III Trials Including Unreported PD-L1 Subgroups
1个月前
已完结
Current Status of Gastric Cancer Screening and Future Perspectives
1个月前
已完结
Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy
1个月前
已完结
Efficacy of the First-line Immune Checkpoint Inhibitor plus Chemotherapy for Gastroesophageal Cancer: A Meta-analysis of Phase III Trials Including Unreported PD-L1 Subgroups
1个月前
已完结
皖公网安备34019202002308
